Displaying drugs 1876 - 1900 of 3688 in total
PMI-001
PMI-001 is a stand-alone, disease-modifying, anti-rheumatic drug (DMARD) being developed by Phytomedics Inc. It is an extract of the roots of an undisclosed perennial shrub which interferes with the production of IL-2 and COX-2 proteins, for the potential treatment of autoimmune diseases, such as rheumatoid arthritis, lupus erythematosus and psoriasis.
Investigational
Matched Name: … PMI-001 …
Matched Description: … PMI-001 is a stand-alone, disease-modifying, anti-rheumatic drug (DMARD) being developed by Phytomedics …
Matched Description: … PMI-001 is a stand-alone, disease-modifying, anti-rheumatic drug (DMARD) being developed by Phytomedics …
8-epi-Cyanocobalamin
Experimental
Matched Synonyms: … 8-Epicobalamine ... Cyano-8-epicobalamin …
Matched Name: … 8-epi-Cyanocobalamin …
Matched Name: … 8-epi-Cyanocobalamin …
D3S-001
D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.g12c Mutation).
Investigational
Matched Name: … D3S-001 …
Matched Description: … D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination …
Matched Description: … D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination …
AKI-001
AKI-001 is an aurora kinase inhibitor.
Experimental
Matched Name: … AKI-001 …
Matched Iupac: … ethyl-7,7,16-trimethyl-5,11,14,15-tetraazapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,17}]icosa-1(12),2(10 …
Matched Description: … AKI-001 is an aurora kinase inhibitor. …
Matched Iupac: … ethyl-7,7,16-trimethyl-5,11,14,15-tetraazapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,17}]icosa-1(12),2(10 …
Matched Description: … AKI-001 is an aurora kinase inhibitor. …
DNB-001
DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma. In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve.
Investigational
Matched Name: … DNB-001 …
Matched Description: … DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed ... In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective …
Matched Description: … DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed ... In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective …
PCLX-001
PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational
Matched Name: … PCLX-001 …
Matched Description: … Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high ... PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by [Pacylex Pharmaceuticals …
Matched Description: … Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high ... PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by [Pacylex Pharmaceuticals …
NB-001
NB-001 has been investigated for the treatment of Recurrent Herpes Labialis.
Investigational
Matched Name: … NB-001 …
Matched Description: … NB-001 has been investigated for the treatment of Recurrent Herpes Labialis. …
Matched Description: … NB-001 has been investigated for the treatment of Recurrent Herpes Labialis. …
10-hydroxycamptothecin
10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)).
Investigational
Matched Name: … 10-hydroxycamptothecin …
Matched Description: … 10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in …
Matched Description: … 10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in …
CODA-001
CODA-001 is under investigation in clinical trial NCT01165450 (Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects).
Investigational
Matched Name: … CODA-001 …
Matched Description: … CODA-001 is under investigation in clinical trial NCT01165450 (Efficacy and Safety Study of Nexagon for …
Matched Description: … CODA-001 is under investigation in clinical trial NCT01165450 (Efficacy and Safety Study of Nexagon for …
BS-001
BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell) for human use (rHSV2hGM-CSF).
Investigational
Matched Name: … BS-001 …
Matched Description: … BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell …
Matched Description: … BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell …
HTPEP-001
HTPEP-001 is a novel peptide that works to inhibit the activation of transforming growth factor beta (TGF-β). It is being investigated for the treatment of fibrosis.
Investigational
Matched Name: … HTPEP-001 …
Matched Description: … HTPEP-001 is a novel peptide that works to inhibit the activation of transforming growth factor beta …
Matched Description: … HTPEP-001 is a novel peptide that works to inhibit the activation of transforming growth factor beta …
QGC-001
QGC001 has been used in trials studying the treatment of Essential Hypertension.
Investigational
Matched Name: … QGC-001 …
CER-001
CER-001 is a negatively charged lipoprotein particle comprising human recombinant apolipoprotein A-I and two phospholipids: sphingomyelin and dipalmitoylphosphatidylglycerol. It is under investigation for the treatment of lecithin-cholesterol acyltransferase (LCAT) deficiencies.
Investigational
Matched Name: … CER-001 …
Matched Description: … CER-001 is a negatively charged lipoprotein particle comprising human recombinant apolipoprotein A-I …
Matched Description: … CER-001 is a negatively charged lipoprotein particle comprising human recombinant apolipoprotein A-I …
8-oxo-dGMP
Experimental
Matched Synonyms: … 8-OH-Dgmp ... 2'-deoxy-7,8-dihydro-8-oxo-5'-guanylic acid ... 8-hydroxydeoxyguanosine 5'-monophosphate …
Matched Name: … 8-oxo-dGMP …
Matched Name: … 8-oxo-dGMP …
8-hydroxy-2'-deoxyguanosine
Experimental
Matched Synonyms: … 8-OHdG ... 8-Oxo-dG ... 8-Oxoguanosine …
Matched Name: … 8-hydroxy-2'-deoxyguanosine …
Matched Iupac: … 2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one …
Matched Name: … 8-hydroxy-2'-deoxyguanosine …
Matched Iupac: … 2-amino-8-hydroxy-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one …
Human Interleukin 8
Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes).
Investigational
Matched Synonyms: … INTERLEUKIN 8 ... INTERLEUKIN 8 (HUMAN) …
Matched Name: … Human Interleukin 8 …
Matched Description: … Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes …
Matched Categories: … Interleukin-8, antagonists & inhibitors …
Matched Name: … Human Interleukin 8 …
Matched Description: … Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes …
Matched Categories: … Interleukin-8, antagonists & inhibitors …
9-(2-carboxyethyl)-10-methylanthracene endoperoxide
Experimental
Matched Synonyms: … [2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE …
Matched Name: … 9-(2-carboxyethyl)-10-methylanthracene endoperoxide …
Matched Iupac: … 3-[(1s,8s)-8-methyl-15,16-dioxatetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9(14),10,12-hexaen-1- …
Matched Name: … 9-(2-carboxyethyl)-10-methylanthracene endoperoxide …
Matched Iupac: … 3-[(1s,8s)-8-methyl-15,16-dioxatetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9(14),10,12-hexaen-1- …
YS-ON-001
YS-ON-001 is a combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium).
Investigational
Matched Name: … YS-ON-001 …
Matched Description: … YS-ON-001 is a combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly …
Matched Description: … YS-ON-001 is a combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly …
10-decarboxymethylaclacinomycin A
Experimental
Matched Name: … 10-decarboxymethylaclacinomycin A …
Matched Iupac: … (8S,10S)-10-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-{[(2R,4S,5R,6S)-4-hydroxy-6-methyl-5-{[(2R,6R)-6-methyl ... -5-oxooxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-8-ethyl-1,8,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene …
Matched Iupac: … (8S,10S)-10-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-{[(2R,4S,5R,6S)-4-hydroxy-6-methyl-5-{[(2R,6R)-6-methyl ... -5-oxooxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-8-ethyl-1,8,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene …
AAV2/8.TBG.hARSB
Investigational
Matched Synonyms: … Adeno-associated viral vector serotype 8 with liver-specific thyroxinebinding globulin (TBG) promoter …
Matched Name: … AAV2/8.TBG.hARSB …
Matched Name: … AAV2/8.TBG.hARSB …
3-(10-methyl-9-anthryl)propanoic acid
Experimental
Matched Synonyms: … 3-(10-methyl-9-anthryl)propionic acid ... 3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
ADL 10-0101
ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment of inflammatory pain, itch and visceral pain. Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at...
Investigational
Matched Name: … ADL 10-0101 …
Matched Description: … ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. ... Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment ... Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at therapeutic …
Matched Description: … ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. ... Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment ... Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at therapeutic …
8-anilinonaphthalene-1-sulfonic acid
Experimental
Matched Synonyms: … 1-Anilino-8-naphthalenesulfonate ... 1-anilino-8-naphthalenesulfonic acid ... 8-Anilino-1-naphthalene sulfonic acid …
Matched Name: … 8-anilinonaphthalene-1-sulfonic acid …
Matched Iupac: … 8-(phenylamino)naphthalene-1-sulfonic acid …
Matched Name: … 8-anilinonaphthalene-1-sulfonic acid …
Matched Iupac: … 8-(phenylamino)naphthalene-1-sulfonic acid …
Displaying drugs 1876 - 1900 of 3688 in total